IDERA PHARMACEUTICALS, INC. Separation Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to Executive Transition and Separation Agreement, by and among Vincent Milano and Aceragen, Inc., dated February 10, 2023
Separation Agreements
IDERA PHARMACEUTICALS, INC.
Biotechnology
PA
2023
Executive Separation Agreement, dated as of August 15, 2023, entered into by and between Aceragen, Inc. and John Taylor
Separation Agreements
IDERA PHARMACEUTICALS, INC.
2023
Amendment No. 1 to Executive Transition and Separation Agreement, by and among Daniel Soland and Aceragen, Inc., dated February 10, 2023
Separation Agreements
IDERA PHARMACEUTICALS, INC.
Biotechnology
PA
2023
Executive Transition and Separation Agreement by and among Daniel Soland and Idera Pharmaceuticals, Inc., dated September 28, 2022
Separation Agreements
IDERA PHARMACEUTICALS, INC.
Biotechnology
PA
2022
Executive Transition and Separation Agreement by and among Vincent Milano and Idera Pharmaceuticals, Inc., dated September 28, 2022
Separation Agreements
IDERA PHARMACEUTICALS, INC.
Biotechnology
PA
2022
SEPARATION AGREEMENT AND RELEASE OF CLAIMS
Separation Agreements
IDERA PHARMACEUTICALS, INC.
Biotechnology
MA
2017